{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:00:39Z","timestamp":1792674039358,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,18]],"date-time":"2014-05-18T00:00:00Z","timestamp":1400371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Burkitt lymphoma (BL) is an aggressive malignancy that arises from B-cells and belongs to the group of Non-Hodgkin lymphomas (NHL). Due to the lack of appropriate <jats:italic>in vivo<\/jats:italic> models NHL research is mainly performed <jats:italic>in vitro<\/jats:italic>. Here, we studied the use of the chick chorioallantoic membrane (CAM) for the generation of human BL xenograft tumors, which we compared with known characteristics of the human disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In order to generate experimental BL tumors, we inoculated human BL2B95 and BL2-GFP cells on the CAM. BL2B95 xenograft-tumors were grown for seven days and subsequently analyzed with transmission electron and immunofluorescence microscopy, as well as histological staining approaches. BL2-GFP cells were studied at regular intervals up to seven days, and their metastatic behavior was visualized with intravital immunofluorescence techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Xenografted BL2B95 cells formed solid tumors in the CAM model with a Ki67-index greater than 90%, preservation of typical tumor markers (CD10, CD19, CD20), a \u2018starry sky\u2019 morphology, production of agyrophilic fibers in the stroma, formation of blood and lymphatic vessels and lymphogenic dissemination of BL2B95 to distant sites. We identified macrophages, lymphocytes and heterophilic granulocytes (chick homolog of neutrophils) as the most abundant immune cells in the experimental tumors. BL2-GFP cells could be traced in real-time during their distribution in the CAM, and the first signs for their dissemination were visible after 2-3 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We show that xenografted BL2B95 cells generate tumors in the CAM with a high degree of cellular, molecular and proliferative concord with the human disease, supporting the application of the CAM model for NHL research with a focus on tumor-stroma interactions. Additionally we report that BL2-GFP cells, grafted on the CAM of ex ovo cultured chick embryos, provide a powerful tool to study lymphogenic dissemination in real-time.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-14-339","type":"journal-article","created":{"date-parts":[[2014,5,18]],"date-time":"2014-05-18T03:02:24Z","timestamp":1400382144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["The chick chorioallantoic membrane as an in vivo xenograft model for Burkitt lymphoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Marcel","family":"Klingenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Eberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Wilting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,18]]},"reference":[{"key":"4536_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS: Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006, 107: 265-276. 10.1182\/blood-2005-06-2508.","journal-title":"Blood"},{"key":"4536_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.semcancer.2009.10.002","volume":"19","author":"A Chene","year":"2009","unstructured":"Chene A, Donati D, Orem J, Mbidde ER, Kironde F, Wahlgren M, Bejarano MT: Endemic Burkitt\u2019s lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. Semin Cancer Biol. 2009, 19: 411-420. 10.1016\/j.semcancer.2009.10.002.","journal-title":"Semin Cancer Biol"},{"key":"4536_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D Burkitt","year":"1958","unstructured":"Burkitt D: A sarcoma involving the jaws in African children. Br J Surg. 1958, 46: 218-223. 10.1002\/bjs.18004619704.","journal-title":"Br J Surg"},{"key":"4536_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/ni826","volume":"3","author":"A Faili","year":"2002","unstructured":"Faili A, Aoufouchi S, Gu\u00e9ranger Q, Zober C, L\u00e9on A, Bertocci B, Weill J-C, Reynaud C-A: AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat Immunol. 2002, 3: 815-821. 10.1038\/ni826.","journal-title":"Nat Immunol"},{"key":"4536_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0014-2964(81)90060-8","volume":"17","author":"S Bertrand","year":"1981","unstructured":"Bertrand S, Berger R, Philip T, Bernheim A, Bryon PA, Bertoglio J, Dor\u00e9 JF, Brunat-Mentigny M, Lenoir GM: Variant translocation in a non endemic case of Burkitt\u2019s lymphoma: t (8;22) in an Epstein\u2013Barr virus negative tumour and in a derived cell line. Eur J Cancer. 1981, 17: 577-584. 10.1016\/0014-2964(81)90060-8.","journal-title":"Eur J Cancer"},{"key":"4536_CR6","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1200\/JCO.2002.07.075","volume":"20","author":"U Kaiser","year":"2002","unstructured":"Kaiser U, Uebelacker I, Abel U, Birkmann J, Tr\u00fcmper L, Schmalenberg H, Karakas T, Metzner B, Hossfeld DK, Bischoff HG, Franke A, Reiser M, M\u00fcller P, Mantovani L, Grundeis M, Rothmann F, von Seydewitz C-U, Mesters RM, Steinhauer EU, Krahl D, Schumacher K, Kneba M, Baudis M, Schmitz N, Pfab R, K\u00f6ppler H, Parwaresch R, Pfreundschuh M, Havemann K: Randomized study to evaluate the use of high-dose therapy as part of primary treatment for \u201caggressive\u201d lymphoma. J Clin Oncol Off J Am Soc Clin Oncol. 2002, 20: 4413-4419. 10.1200\/JCO.2002.07.075.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4536_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/annonc\/mdg249","volume":"14","author":"A Wunderlich","year":"2003","unstructured":"Wunderlich A, Kloess M, Reiser M, Rudolph C, Truemper L, Bittner S, Schmalenberg H, Schmits R, Pfreundschuh M, Loeffler M: German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL): practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin\u2019s lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL). Ann Oncol Off J Eur Soc Med Oncol ESMO. 2003, 14: 881-893. 10.1093\/annonc\/mdg249.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"4536_CR8","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.2174\/138161208785294591","volume":"14","author":"P Macor","year":"2008","unstructured":"Macor P, Secco E, Zorzet S, Tripodo C, Celeghini C, Tedesco F: An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. Curr Pharm Des. 2008, 14: 2023-2039. 10.2174\/138161208785294591.","journal-title":"Curr Pharm Des"},{"key":"4536_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-824X-4-3","volume":"4","author":"J Becker","year":"2012","unstructured":"Becker J, Covelo-Fernandez A, von Bonin F, Kube D, Wilting J: Specific tumor-stroma interactions of EBV-positive Burkitt\u2019s lymphoma cells in the chick chorioallantoic membrane. Vasc Cell. 2012, 4: 3-10.1186\/2045-824X-4-3.","journal-title":"Vasc Cell"},{"key":"4536_CR10","first-page":"24482381","volume":"[Epub ahead of","author":"M Klingenberg","year":"2014","unstructured":"Klingenberg M, Becker J, Eberth S, Kube D, Wilting J: The NADPH oxidase inhibitor imipramine-blue in the treatment of Burkitt\u2019s lymphoma. Mol Cancer Ther. 2014, [Epub ahead of print] PMID: 24482381-","journal-title":"Mol Cancer Ther"},{"key":"4536_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00418-008-0536-2","volume":"130","author":"EI Deryugina","year":"2008","unstructured":"Deryugina EI, Quigley JP: Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. Histochem Cell Biol. 2008, 130: 1119-1130. 10.1007\/s00418-008-0536-2.","journal-title":"Histochem Cell Biol"},{"key":"4536_CR12","first-page":"215","volume":"4","author":"AF Chambers","year":"1990","unstructured":"Chambers AF, Wilson SM, Tuck AB, Denhardt GH, Cairncross JG: Comparison of metastatic properties of a variety of mouse, rat, and human cells in assays in nude mice and chick embryos. Vivo Athens Greece. 1990, 4: 215-219.","journal-title":"Vivo Athens Greece"},{"key":"4536_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ccr.2008.01.031","volume":"13","author":"A Zijlstra","year":"2008","unstructured":"Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP: The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell. 2008, 13: 221-234. 10.1016\/j.ccr.2008.01.031.","journal-title":"Cancer Cell"},{"key":"4536_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1006\/dbio.1996.9993","volume":"176","author":"J Wilting","year":"1996","unstructured":"Wilting J, Birkenh\u00e4ger R, Eichmann A, Kurz H, Martiny-Baron G, Marm\u00e9 D, McCarthy JE, Christ B, Weich HA: VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev Biol. 1996, 176: 76-85. 10.1006\/dbio.1996.9993.","journal-title":"Dev Biol"},{"key":"4536_CR15","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.3390\/ijms13089959","volume":"13","author":"NA Lokman","year":"2012","unstructured":"Lokman NA, Elder ASF, Ricciardelli C, Oehler MK: Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. Int J Mol Sci. 2012, 13: 9959-9970. 10.3390\/ijms13089959.","journal-title":"Int J Mol Sci"},{"key":"4536_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/10428190902878448","volume":"50","author":"Y Ganor","year":"2009","unstructured":"Ganor Y, Grinberg I, Reis A, Cooper I, Goldstein RS, Levite M: Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147\/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo. Leuk Lymphoma. 2009, 50: 985-997. 10.1080\/10428190902878448.","journal-title":"Leuk Lymphoma"},{"key":"4536_CR17","first-page":"401","volume":"10","author":"D Ribatti","year":"1990","unstructured":"Ribatti D, Vacca A, Bertossi M, De Benedictis G, Roncali L, Dammacco F: Angiogenesis induced by B-cell non-Hodgkin\u2019s lymphomas. Lack of correlation with tumor malignancy and immunologic phenotype. Anticancer Res. 1990, 10: 401-406.","journal-title":"Anticancer Res"},{"key":"4536_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s005990050018","volume":"28","author":"A Vacca","year":"1998","unstructured":"Vacca A, Ribatti D, Iurlaro M, Albini A, Minischetti M, Bussolino F, Pellegrino A, Ria R, Rusnati M, Presta M, Vincenti V, Persico MG, Dammacco F: Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res. 1998, 28: 55-68. 10.1007\/s005990050018.","journal-title":"Int J Clin Lab Res"},{"key":"4536_CR19","volume-title":"Romeis - Mikroskopische Technik","author":"M Mulisch","year":"2010","unstructured":"Mulisch M, Welsch U: Romeis - Mikroskopische Technik. 2010, Heidelberg: Spektrum Akademischer Verlag"},{"key":"4536_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ajpath.2012.12.013","volume":"182","author":"N Walther","year":"2013","unstructured":"Walther N, Ulrich A, Vockerodt M, von Bonin F, Klapper W, Meyer K, Eberth S, Pukrop T, Spang R, Tr\u00fcmper L, Kube D: Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt\u2019s lymphoma. Am J Pathol. 2013, 182: 1092-1098. 10.1016\/j.ajpath.2012.12.013.","journal-title":"Am J Pathol"},{"key":"4536_CR21","first-page":"506","volume":"2011","author":"ES Jaffe","year":"2011","unstructured":"Jaffe ES, Pittaluga S: Aggressive B-Cell lymphomas: a review of new and old entities in the who classification. ASH Educ Program Book. 2011, 2011: 506-514.","journal-title":"ASH Educ Program Book"},{"key":"4536_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/blood-2005-04-1458","volume":"107","author":"A Zijlstra","year":"2006","unstructured":"Zijlstra A, Seandel M, Kupriyanova TA, Partridge JJ, Madsen MA, Hahn-Dantona EA, Quigley JP, Deryugina EI: Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. Blood. 2006, 107: 317-327. 10.1182\/blood-2005-04-1458.","journal-title":"Blood"},{"key":"4536_CR23","first-page":"3015","volume":"174","author":"CA Ogden","year":"2005","unstructured":"Ogden CA, Pound JD, Batth BK, Owens S, Johannessen I, Wood K, Gregory CD: Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt\u2019s lymphoma. J Immunol Baltim Md 1950. 2005, 174: 3015-3023.","journal-title":"J Immunol Baltim Md 1950"},{"key":"4536_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10555-011-9281-4","volume":"30","author":"E Tartour","year":"2011","unstructured":"Tartour E, Pere H, Maillere B, Terme M, Merillon N, Taieb J, Sandoval F, Quintin-Colonna F, Lacerda K, Karadimou A, Badoual C, Tedgui A, Fridman WH, Oudard S: Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer Metastasis Rev. 2011, 30: 83-95. 10.1007\/s10555-011-9281-4.","journal-title":"Cancer Metastasis Rev"},{"key":"4536_CR25","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T, Bailey S: Burkitt\u2019s lymphoma. Lancet. 2012, 379: 1234-1244. 10.1016\/S0140-6736(11)61177-X.","journal-title":"Lancet"},{"key":"4536_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/10428199509054750","volume":"20","author":"A Vacca","year":"1995","unstructured":"Vacca A, Ribatti D, Roncali L, Dammacco F: Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma. 1995, 20: 27-38. 10.3109\/10428199509054750.","journal-title":"Leuk Lymphoma"},{"key":"4536_CR27","doi-asserted-by":"publisher","first-page":"e11140","DOI":"10.1371\/journal.pone.0011140","volume":"5","author":"P Secchiero","year":"2010","unstructured":"Secchiero P, Zorzet S, Tripodo C, Corallini F, Melloni E, Caruso L, Bosco R, Ingrao S, Zavan B, Zauli G: Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin\u2019s lymphoma xenografts. PLoS One. 2010, 5: e11140-10.1371\/journal.pone.0011140.","journal-title":"PLoS One"},{"key":"4536_CR28","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1158\/1078-0432.CCR-08-2619","volume":"15","author":"T Numbenjapon","year":"2009","unstructured":"Numbenjapon T, Wang J, Colcher D, Schluep T, Davis ME, Duringer J, Kretzner L, Yen Y, Forman SJ, Raubitschek A: Preclinical results of camptothecin-polymer conjugate (IT-101) in multiple human lymphoma xenograft models. Clin Cancer Res Off J Am Assoc Cancer Res. 2009, 15: 4365-4373. 10.1158\/1078-0432.CCR-08-2619.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"4536_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/1097-0142(196103\/04)14:2<258::AID-CNCR2820140206>3.0.CO;2-7","volume":"14","author":"D Burkitt","year":"1961","unstructured":"Burkitt D, O\u2019Conor GT: Malignant lymphoma in African children. I. A clinical syndrome. Cancer. 1961, 14: 258-269. 10.1002\/1097-0142(196103\/04)14:2<258::AID-CNCR2820140206>3.0.CO;2-7.","journal-title":"Cancer"},{"key":"4536_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/pgmj.38.436.71","volume":"38","author":"D Burkitt","year":"1962","unstructured":"Burkitt D: A tumour syndrome affecting children in tropical Africa. Postgrad Med J. 1962, 38: 71-79. 10.1136\/pgmj.38.436.71.","journal-title":"Postgrad Med J"},{"key":"4536_CR31","first-page":"110","volume":"2","author":"MD Saint-Hubert","year":"2012","unstructured":"Saint-Hubert MD, Brepoels L, Devos E, Vermaelen P, Groot TD, Tousseyn T, Mortelmans L, Mottaghy FM: Molecular imaging of therapy response with (18)F-FLT and (18)F-FDG following cyclophosphamide and mTOR inhibition. Am J Nucl Med Mol Imaging. 2012, 2: 110-121.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"4536_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/bjc.1963.7","volume":"17","author":"DH Wright","year":"1963","unstructured":"Wright DH: Cytology and histochemistry of the Burkitt lymphoma. Br J Cancer. 1963, 17: 50-55. 10.1038\/bjc.1963.7.","journal-title":"Br J Cancer"},{"key":"4536_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ijc.2910470502","volume":"47","author":"SS Joshi","year":"1991","unstructured":"Joshi SS, Deboer JM, Strandjord SJ, Pirruccello SJ, Sanger WG, Weisenburger DD, Sharp JG: Characterization of a newly established human Burkitt\u2019s lymphoma cell line, OMA\u2012BL\u20121. Int J Cancer. 1991, 47: 643-648. 10.1002\/ijc.2910470502.","journal-title":"Int J Cancer"},{"key":"4536_CR34","first-page":"877","volume":"36","author":"BG Achong","year":"1966","unstructured":"Achong BG, Epstein MA: Fine structure of the Burkitt tumor. J Natl Cancer Inst. 1966, 36: 877-887.","journal-title":"J Natl Cancer Inst"},{"key":"4536_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2141.2005.05695.x","volume":"130","author":"I Kadowaki","year":"2005","unstructured":"Kadowaki I, Ichinohasama R, Harigae H, Ishizawa K, Okitsu Y, Kameoka J, Sasaki T: Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol. 2005, 130: 869-877. 10.1111\/j.1365-2141.2005.05695.x.","journal-title":"Br J Haematol"},{"key":"4536_CR36","first-page":"671","volume":"88","author":"E Crivellato","year":"2003","unstructured":"Crivellato E, Nico B, Vacca A, Ribatti D: B-cell non-Hodgkin\u2019s lymphomas express heterogeneous patterns of neovascularization. Haematologica. 2003, 88: 671-678.","journal-title":"Haematologica"},{"key":"4536_CR37","doi-asserted-by":"publisher","first-page":"133S","DOI":"10.1177\/1066896910370614","volume":"18","author":"J Forteza-Vila","year":"2010","unstructured":"Forteza-Vila J, Fraga M: Burkitt lymphoma and diffuse aggressive B-Cell lymphoma. Int J Surg Pathol. 2010, 18: 133S-135S. 10.1177\/1066896910370614.","journal-title":"Int J Surg Pathol"},{"key":"4536_CR38","unstructured":"NOD SCID Mouse Immunodeficient Mice Charles River. http:\/\/www.criver.com\/products-services\/basic-research\/find-a-model\/nod-scid-mouse,"},{"key":"4536_CR39","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1038\/bjc.2013.495","volume":"109","author":"E Liniker","year":"2013","unstructured":"Liniker E, Harrison M, Weaver JMJ, Agrawal N, Chhabra A, Kingshott V, Bailey S, Eisen TGG, Corrie PG: Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2\u00a0years (2009-2010). Br J Cancer. 2013, 109: 2051-2057. 10.1038\/bjc.2013.495.","journal-title":"Br J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-339\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:53:30Z","timestamp":1630554810000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,18]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4536"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-339","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,18]]},"assertion":[{"value":"29 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"339"}}